Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. - Wikidata - awgldk - TriplyDB

Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.

Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.

http://www.wikidata.org/entity/Q34785638

about

Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease Alternative splicing of the neurofibromatosis type I pre-mRNA A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor Nf1 has an essential role in endothelial cells Solitary colonic neurofibroma in a patient with transient segmental colitis: case report.At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension Optimizing biologically targeted clinical trials for neurofibromatosis.Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006)Twenty questions in genetic medicine--an assessment of World Wide Web databases for genetics information at the point of care.Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.Fatal retroperitoneal bleeding caused by neurofibromatosis: a case report and review of the literature Pulmonary arterial hypertension associated with neurofibromatosis type 1.Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.Moyamoya syndrome and neurofibromatosis type 1 The genetic basis of aortic aneurysm Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis.Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional study.Neurofibromatosis type 1-associated hypertension secondary to coarctation of the thoracic aorta Spontaneous aortic rupture in a patient with neurofibromatosis type 1.Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation Perioperative management of neurofibromatosis type 1.A Pleural Solitary Fibrous Tumor, Multiple Gastrointestinal Stromal Tumors, Moyamoya Disease, and Hyperparathyroidism in a Patient Associated with NF1 Partitioning the heart: mechanisms of cardiac septation and valve development Stent-assisted Coil Embolization of Petrous ICA in a Teenager with Neurofibromatosis.Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos.Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.Neurofibromatosis type 1 complicated by atypical coarctation of the thoracic aorta Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a review of the literature.Lessons on the pathogenesis of aneurysm from heritable conditions Monogenic vessel diseases related to ischemic stroke: a clinical approach.Forensic considerations in cases of neurofibromatosis--an overview.Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management.Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.Spontaneous Renal Artery Dissection in a Patient with Neurofibromatosis Type I

P2860

Q24645526-B6FA3592-E6FF-4E10-B840-3F3F5379ED67 Q26865241-6534BD39-772F-4505-BA01-FF9B40E1702E Q27003534-79EC1348-19B3-4769-96E9-70D804D73D5C Q28507662-787CAA15-FD4B-4C78-8F31-23FD9019AAB6 Q30419055-809B8924-DD9C-45D5-9ECF-C6508CA6FF65 Q30438226-D02203F0-8246-4659-ACA2-BAAB3EFEC35B Q30438898-3925DDD3-8B9F-4096-88E2-7449ABA32055 Q30475780-BC83ECE0-8EDD-4E41-80C7-28EA48687AB3 Q30483973-4C81AE3F-A1DA-4D7F-B967-4881CAA38E23 Q30492592-DAD23B0C-CE72-431A-ABBE-FF3A43170D18 Q30706016-BDDD9487-D789-4876-8FF0-4C6227D649EF Q30894133-896082E8-6F3B-4133-8E90-CE08720067C4 Q33161531-40ABF2EF-7A19-4325-A11B-E8A0255D4E03 Q33685670-102898CE-62EE-402F-9471-5A4C44B2207A Q33925617-F568F655-1D7C-4DA1-A4E5-69754B66326F Q34083174-1B3BB8D6-1BE6-4E37-8056-6F35E5BFEB32 Q34474278-5F1C8B22-1ACB-4E07-86F1-212120ED73B5 Q34623530-F006968D-864A-459A-992A-147920E064BE Q35227687-A48DD1BC-4F6E-441C-9FFD-9038B2AE1661 Q35871534-91E66259-EDCB-442A-BCE7-81EC61B9BC45 Q35944775-C6303743-9754-45E1-AAAD-22DC749A5EAD Q36071038-76C6EEDA-F940-466E-A6A9-FAA49AD34A33 Q36084232-0B1EB2E0-936D-42E5-A3A6-BF5829895899 Q36178682-25C2DAE1-57D0-498C-AB35-525537F16E5B Q36225579-2AA04C57-5400-49BF-8D4E-1AEEB9FAE8E7 Q36395077-971E9C4E-AD13-49FA-92E9-D5390C2B2277 Q36468302-A02DAA7A-8FCD-44F0-B202-D760B4E15E5D Q36483309-652DA3AA-6A79-4938-81AC-BE60F5CF04BE Q36580738-EE4AA267-325D-4A12-A0FC-3388ABBFF1C4 Q36608863-45317B9E-15BF-487D-AFF2-FF2AF1FF7AF8 Q36653938-40FF2E2D-9425-469E-9739-1E3A17373FE8 Q36668971-456A3A23-1E26-4A64-8B57-F756FC264118 Q36702800-ACF4FA23-5168-455D-8851-34C2D8A6DA0C Q36743487-7C26C13B-4C18-4EE4-B907-1865AAE9A6F9 Q36756427-5299E040-D093-4072-AD46-9C06BA770538 Q36853643-1F3592D1-E808-4930-A3DE-F46BBBE5908A Q36889065-F5D8B6D9-C3F5-4667-A12C-175D382B5180 Q37293359-1D456346-D139-4FAB-9CAA-0D754FF443F7 Q37353815-AB9BF4DE-5A50-4049-9EE5-9662EC496825 Q37404730-85E8E4A7-523D-457B-B074-BE3996A16365

P2860

Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.

http://www.wikidata.org/entity/Q34785638

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@ast

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@en

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@nl

type

label

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@ast

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@en

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@nl

prefLabel

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@ast

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@en

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@nl

P1433

Q34785638-E1A80A3E-C26E-4EEC-9F99-BCC1CAFD3138

P1476

Q34785638-92D38064-DFB8-437D-AD10-6E7621157F57

P2093

Q34785638-0B705AEA-F509-4EB9-857F-DE78F5944992

Q34785638-33179AF5-ED2F-4F17-A80B-26B36AF4B21E

Q34785638-5EBF4DB4-43ED-4382-861C-E9EB69431D6E

Q34785638-AF9DDBF4-A214-43EE-B5F4-6A37696C4A1E

Q34785638-D089DC08-AC32-4234-8C5B-BED1D08BB114

Q34785638-D6448B4E-D555-424B-BAB0-B60EDBC9ED73

Q34785638-F169D63F-8A32-4120-B087-C89A4527AEA0

P2860

Q34785638-0284CAEE-2AF8-4173-976D-D846CE4DD731

Q34785638-1783A290-0F87-493D-B5A7-A2A975051E4F

Q34785638-1A568FD2-5759-46BB-89C0-76067F5A58A8

Q34785638-1E3F217D-70A4-4C29-9469-8F30DADDE5D7

Q34785638-272D8E82-84CD-401A-A7C1-FDBC71DF2DC2

Q34785638-3E68B43B-43B5-46E5-8D81-5511246AB8B3

Q34785638-616B7E05-A1E5-4D86-8F3E-3A5ADC0FBC2A

Q34785638-74216987-B45F-424B-BAAF-C683153DA83F

Q34785638-7D6EB996-A7B3-420D-A41A-B51BDDFD3F12

Q34785638-93FD7C87-6025-44A9-B1ED-7B348DF41CE1

P2888

Q34785638-9E8889F6-D043-4D6C-9366-5B787FD9D425

P304

Q34785638-082FBAF2-20D2-47E7-92CF-5BCB40C6F7C6

P31

Q34785638-3B1574C6-E09C-4067-A0DF-D196C53B39CC

P356

Q34785638-B1047C67-D8BD-437D-B44B-79E899951891

P407

Q34785638-0F40EAC8-98CC-467D-B78A-5A9CE349F97E

P433

Q34785638-87A4D67C-2B40-4C43-8B80-83FEFA12448A

P478

Q34785638-601AAD1D-3240-4648-AFF6-A231F6AE84CC

P50

Q34785638-56CFBE9D-DBE0-4C57-8671-C2EC40EA34F6

Q34785638-872CA8AC-B904-4176-8F97-6C47C268083B

P577

Q34785638-261EEC62-FEDD-47E3-8624-21399E744269

P5875

Q34785638-2344EF7E-217F-4F1F-A180-B1927485B80C

P6179

Q34785638-4AA636D4-F164-4E5B-9549-B6D02F8D8B32

P698

Q34785638-477F7590-77AB-4F12-8681-DC8791E1FA4F

P921

Q34785638-646F4AEA-7848-446B-9BC4-61A129A0F45E

P356

00125817-200205000-00002

P1433

Genetics in Medicine

P1476

Cardiovascular disease in neur ...... NF1 Cardiovascular Task Force.

@en

P2093

Angela E Lin

http://www.w3.org/2001/XMLSchema#string

Bruce McManus

http://www.w3.org/2001/XMLSchema#string

Bruce R Korf

http://www.w3.org/2001/XMLSchema#string

J M Friedman

http://www.w3.org/2001/XMLSchema#string

Jack Arbiser

http://www.w3.org/2001/XMLSchema#string

Jonathan A Epstein

http://www.w3.org/2001/XMLSchema#string

Stephen J Huot

http://www.w3.org/2001/XMLSchema#string

P2860

Insights into the pathogenesis of neurofibromatosis 1 vasculopathy

Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues

Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules

Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo

Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

Type 1 neurofibromatosis and the pediatric patient.

Percutaneous transluminal renal angioplasty in neurofibromatosis.

Hemodynamic significance of renal artery stenosis: digital subtraction angiography versus systolically gated three-dimensional phase-contrast MR angiography.

P2888

00125817-200205000-00002

P304

105-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00125817-200205000-00002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

David H Gutmann

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11207506

http://www.w3.org/2001/XMLSchema#string

P6179

1031698700

http://www.w3.org/2001/XMLSchema#string

P698

12180143

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease